Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.21% |
| 2 | Healthcare | 10.45% |
| 3 | Technology | 8.65% |
| 4 | Financials | 8.6% |
| 5 | Consumer Discretionary | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
CALL
Universal Health Services
UHS
$10.2B
| $1.44M | ﹤0.01% |
+10,000
| New | +$1.43M |
|
2777
BioLife Solutions
BLFS
$1.82B
| $1.43M | ﹤0.01% |
88,639
+28,065
| +46% | +$456K |
|
2778
Itron
ITRI
$4.35B
| $1.43M | ﹤0.01% |
17,078
+10,457
| +158% | +$823K |
|
2779
Insperity
NSP
$1.98B
| $1.43M | ﹤0.01% |
16,650
-147,472
| -90% | -$12.8M |
|
2780
Schwab Short-Term US Treasury ETF
SCHO
$13.1B
| $1.43M | ﹤0.01% |
56,638
-209,666
| -79% | -$5.3M |
|
2781
Adient
ADNT
$1.45B
| $1.43M | ﹤0.01% |
67,260
+34,095
| +103% | +$756K |
|
2782
AngloGold Ashanti
AU
$59.9B
| $1.43M | ﹤0.01% |
63,914
-1,134,788
| -95% | -$22.8M |
|
2783
Pearson
PSO
$10B
| $1.43M | ﹤0.01% |
169,358
-39,983
| -19% | -$344K |
|
2784
Saia
SAIA
$9.39B
| $1.43M | ﹤0.01% |
15,309
-17,296
| -53% | -$1.64M |
|
2785
Advanced Energy
AEIS
$11.5B
| $1.42M | ﹤0.01% |
20,003
+15,822
| +378% | +$984K |
|
2786
Old Second Bancorp
OSBC
$1.28B
| $1.42M | ﹤0.01% |
105,660
+62,742
| +146% | +$783K |
|
|
VAR
2787
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.42M | ﹤0.01% |
+10,000
| New | +$1.28M |
|
2788
Enerpac Tool Group
EPAC
$1.92B
| $1.42M | ﹤0.01% |
54,436
-47,716
| -47% | -$1.16M |
|
|
KAMN
2789
DELISTED
Kaman Corp
KAMN
| $1.42M | ﹤0.01% |
21,471
-177,034
| -89% | -$11.1M |
|
2790
Nelnet
NNI
$4.56B
| $1.41M | ﹤0.01% |
+24,171
| New | +$1.48M |
|
2791
iShares MSCI Taiwan ETF
EWT
$11.8B
| $1.41M | ﹤0.01% |
34,200
-37,883
| -53% | -$1.49M |
|
2792
CALL
Veeva Systems
VEEV
$45.8B
| $1.41M | ﹤0.01% |
+10,000
| New | +$1.47M |
|
|
AKCA
2793
DELISTED
Akcea Therapeutics Inc
AKCA
| $1.4M | ﹤0.01% |
+82,646
| New | +$1.54M |
|
2794
Bank7 Corp
BSVN
$499M
| $1.39M | ﹤0.01% |
73,473
-11,176
| -13% | -$209K |
|
2795
PACCAR
PCAR
$66.6B
| $1.39M | ﹤0.01% |
26,375
-308,353
| -92% | -$15.9M |
|
2796
CALL
Prothena Corp
PRTA
$467M
| $1.39M | ﹤0.01% |
+87,900
| New | +$943K |
|
|
BNFT
2797
DELISTED
Benefitfocus, Inc.
BNFT
| $1.39M | ﹤0.01% |
63,422
+14,124
| +29% | +$320K |
|
2798
AudioCodes
AUDC
$247M
| $1.39M | ﹤0.01% |
54,019
+32,263
| +148% | +$706K |
|
2799
Toyota
TM
$227B
| $1.39M | ﹤0.01% |
9,874
+8,255
| +510% | +$1.15M |
|
2800
Dine Brands
DIN
$422M
| $1.39M | ﹤0.01% |
16,611
-74,092
| -82% | -$5.76M |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $4.28B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.